Abstract:It is important to characterize the temporal trajectories of disease-related biomarkers in order to monitor progression and identify potential points of intervention. These are especially important for neurodegenerative diseases, as therapeutic intervention is most likely to be effective in the preclinical disease stages prior to significant neuronal damage. Neuroimaging allows for the measurement of structural, functional, and metabolic integrity of the brain at the level of voxels, whose volumes are on the order of mm(3). These voxelwise measurements provide a rich collection of disease indicators. Longitudinal neuroimaging studies enable the analysis of changes in these voxelwise measures. However, commonly used longitudinal analysis approaches, such as linear mixed effects models, do not account for the fact that individuals enter a study at various disease stages and progress at different rates, and generally consider each voxelwise measure independently. We propose a multivariate nonlinear mixed effects model for estimating the trajectories of voxelwise neuroimaging biomarkers from longitudinal data that accounts for such differences across individuals. The method involves the prediction of a progression score for each visit based on a collective analysis of voxelwise biomarker data within an expectation-maximization framework that efficiently handles large amounts of measurements and variable number of visits per individual, and accounts for spatial correlations among voxels. This score allows individuals with similar progressions to be aligned and analyzed together, which enables the construction of a trajectory of brain changes as a function of an underlying progression or disease stage. We apply our method to studying cortical β-amyloid deposition, a hallmark of preclinical Alzheimer's disease, as measured using positron emission tomography. Results on 104 individuals with a total of 300 visits suggest that precuneus is the earliest cortical region to accumulate amyloid, closely followed by the cingulate and frontal cortices, then by the lateral parietal cortex. The extracted progression scores reveal a pattern similar to mean cortical distribution volume ratio (DVR), an index of global brain amyloid levels. The proposed method can be applied to other types of longitudinal imaging data, including metabolism, blood flow, tau, and structural imaging-derived measures, to extract individualized summary scores indicating disease progression and to provide voxelwise trajectories that can be compared between brain regions.

Joint analysis of multivariate longitudinal, imaging, and time-to-event data

Joint model for survival and multivariate sparse functional data with application to a study of Alzheimer's Disease

A multivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imaging

Bayesian inference and dynamic prediction of multivariate joint model with functional data: An application to Alzheimer's disease

Joint Modeling of Biomarker Cascades Along An Unobserved Disease Progression with Differentiate Covariate Effects: An Application in Alzheimer's Disease

High-Order Multi-Task Feature Learning to Identify Longitudinal Phenotypic Markers for Alzheimer's Disease Progression Prediction.

Joint Association Discovery and Diagnosis of Alzheimer's Disease by Supervised Heterogeneous Multiview Learning.

A joint model for multiple dynamic processes and clinical endpoints: application to Alzheimer's disease

Machine learning on longitudinal multi-modal data enables the understanding and prognosis of Alzheimer's disease progression

Exploration of Imaging Genetic Biomarkers of Alzheimer's Disease Based on a Machine Learning Method

Machine learning on longitudinal multi-modal data enabling the understanding and prognosis of Alzheimer’s disease progression

Bayesian Joint Model with Latent Time Shifts for Multivariate Longitudinal Data with Informative Dropout

Probabilistic Clustering using Shared Latent Variable Model for Assessing Alzheimers Disease Biomarkers

Dynamic Survival Prediction Using Sparse Longitudinal Images via Multi-Dimensional Functional Principal Component Analysis

Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer's Disease

Joint Modeling of Transitional Patterns of Alzheimer'S Disease

Identifying AD-Sensitive and Cognition-Relevant Imaging Biomarkers Via Joint Classification and Regression.

Imaging Genetics Study Based on a Temporal Group Sparse Regression and Additive Model for Biomarker Detection of Alzheimer's Disease.

A Partially Functional Linear Modeling Framework for Integrating Genetic, Imaging, and Clinical Data

Joint Models for Time-to-Event Data and Longitudinal Biomarkers of High Dimension

From Phenotype to Genotype: an Association Study of Longitudinal Phenotypic Markers to Alzheimer's Disease Relevant SNPs.